EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling. - Wikidata - awgldk - TriplyDB

EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling.

EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling.

http://www.wikidata.org/entity/Q34584872

about

EZH2 methyltransferase and H3K27 methylation in breast cancer Post-translational modification-regulated leukocyte adhesion and migration Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies Early Life Adverse Environmental Exposures Increase the Risk of Uterine Fibroid Development: Role of Epigenetic Regulation Targeting EZH2 in cancer EZH2 in normal hematopoiesis and hematological malignancies SLUG: Critical regulator of epithelial cell identity in breast development and cancer Epigenetics in breast cancer: what's new?Sapacitabine for cancer EZH2 in Bladder Cancer, a Promising Therapeutic Target Histone methylation modifiers in cellular signaling pathways Diverse involvement of EZH2 in cancer epigenetics Raf kinases in cancer-roles and therapeutic opportunities The role of EZH2 in tumour progression Arsenic-induced sub-lethal stress reprograms human bronchial epithelial cells to CD61¯ cancer stem cells Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis The hTERT promoter enhances the antitumor activity of an oncolytic adenovirus under a hypoxic microenvironment Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERα expression in initially ERα+ breast cancer cells.EZH2: not EZHY (easy) to deal.A covalently bound inhibitor triggers EZH2 degradation through CHIP-mediated ubiquitination.Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2.A c-Myc-regulated stem cell-like signature in high-risk neuroblastoma: A systematic discovery (Target neuroblastoma ESC-like signature).PAF and EZH2 induce Wnt/β-catenin signaling hyperactivation.Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transition The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects Biomarkers to Target Heterogeneous Breast Cancer Stem Cells Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target.Functional and therapeutic significance of EZH2 in urological cancers Concise review: breast cancer stem cells: regulatory networks, stem cell niches, and disease relevance Regulation and Role of EZH2 in Cancer Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations.VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy The epigenetics of epithelial-mesenchymal plasticity in cancer.The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.Quantitative analysis of EZH2 expression and its correlations with lung cancer patients' clinical pathological characteristics.Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinase c-Rel regulates Ezh2 expression in activated lymphocytes and malignant lymphoid cells Propagation of human prostate cancer stem-like cells occurs through EGFR-mediated ERK activation.

P2860

Q24633788-B73BA29A-7E4C-44D4-9111-798F2EF4CF09 Q26753208-385195C1-2301-487B-A784-FA63B3946AEF Q26765342-3C90C8A3-8E80-4AF1-BF83-4DCC9EF74672 Q26765991-99A0E431-AFBA-494D-8318-9C2379DF2D38 Q26769027-CAEFEE57-705E-4434-AF57-DBFB0A3A1F7C Q26779821-828803C4-79D9-4680-8682-BD5FE75FE402 Q26865846-21E66E2F-B6F6-4ADD-856D-A7FB92FE6864 Q26991779-12CD0F69-6360-499D-95D5-0C661EAFC4DC Q27024675-18FB41B0-E593-4682-8A81-DEC18D8C37B0 Q28082054-A354A280-B193-42D5-B7F5-9B71BDC3CFA0 Q28082123-07772B35-808E-43B2-B45D-815F1B040991 Q28084911-D1E7CF1F-2FEF-4484-9577-FD717D3335F1 Q28237793-9DBDCC43-89AD-4FD2-9B8D-C8E74657FF95 Q28255886-A65D6CE2-172E-4B69-956D-598DA16C7AFF Q28385362-BD9A1B12-7A1D-4345-975E-20AF873CE2FA Q28393302-926B0B7E-ACE7-40CA-B1B9-E4ABBDCCE07F Q28728396-463BDF07-5EDA-4E0F-BBB3-CE92EB7F237C Q33591225-C7CD1848-EF2F-4C84-BC3D-33A8557ABE7A Q33610902-4F723750-90D0-44C4-BF86-E668EFE04E8C Q33626131-CC5C4B7B-5E1D-42C4-9847-8FCFB9B9CEA4 Q33667093-19EEAEF8-7086-4FA8-A9D5-960D8D068149 Q33669451-3A7A62E7-E3F4-493D-A082-22FD69B9845D Q33693019-C6C46C5B-B4EB-417C-A88E-835F11570EA9 Q33739319-D1E05490-0E4F-43F0-B260-D4CA2B086155 Q33741948-EF672923-E990-47E7-8EFF-0FFB116E7850 Q33759691-2D612AC0-C85F-4250-B22C-DBB4C6516779 Q33801377-C0021D80-E7B8-4CEE-AE9D-3F54F9680330 Q33811149-9C8F4E1C-A14C-4714-9568-1A2A748EC7CA Q33914216-E3A2AD9F-2B67-4DFD-941A-CE8106222620 Q33914244-60F9D7D1-6975-42F3-ACE6-622312FB0FBF Q33975619-2EB2354C-285D-4801-A9DD-7F044BFEDCDF Q34043370-12B77A11-C61C-4F0D-80BC-013E9C4D4624 Q34092485-3D91023C-4E85-4D25-A53A-005149F96956 Q34310069-6ADEE9B1-7A56-464A-AB87-E9DF2E2EC494 Q34310378-B9FE957E-000F-472F-8ABB-AD2981B33680 Q34334347-DAA8CF10-8425-4662-860F-782DBF650242 Q34362220-FCF0C36B-85F9-403F-A457-7685FE428BC6 Q34451033-A7655684-A107-4A65-8CCA-A7BBF3EEE812 Q34509582-AE62D50E-11A3-451B-92FC-A1436D4FFD66 Q34689170-71958CFA-99F3-4DD5-9F53-8E757DF67282

P2860

EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling.

http://www.wikidata.org/entity/Q34584872

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

EZH2 promotes expansion of bre ...... n of RAF1-β-catenin signaling.

@ast

EZH2 promotes expansion of bre ...... n of RAF1-β-catenin signaling.

@en

EZH2 promotes expansion of bre ...... n of RAF1-β-catenin signaling.

@nl

type

label

EZH2 promotes expansion of bre ...... n of RAF1-β-catenin signaling.

@ast

EZH2 promotes expansion of bre ...... n of RAF1-β-catenin signaling.

@en

EZH2 promotes expansion of bre ...... n of RAF1-β-catenin signaling.

@nl

prefLabel

EZH2 promotes expansion of bre ...... n of RAF1-β-catenin signaling.

@ast

EZH2 promotes expansion of bre ...... n of RAF1-β-catenin signaling.

@en

EZH2 promotes expansion of bre ...... n of RAF1-β-catenin signaling.

@nl

P1433

Q34584872-48829C40-A356-4148-99AA-0ACF1EFF2568

P1476

Q34584872-0992A4D7-F22B-4D9C-838D-4A353E691CAF

P2093

Q34584872-0517CD2B-97D0-4F2F-A923-83E9C3DF3E2D

Q34584872-56A91225-0441-46A4-8991-891BCC9E40EA

Q34584872-612CE1EA-C6CA-43B1-BC83-54006B330C41

Q34584872-6CB8F5AF-A42B-44BE-AAE1-B242E10EC870

Q34584872-96D93C9B-500E-4B38-B344-03DA4F7E9009

Q34584872-A90C0447-0F45-4F48-B7FF-5A5CA1C4177F

Q34584872-EF1CBE92-7AEF-41F5-8138-D3A73AEEB5F3

P2860

Q34584872-12309E44-2E9B-4997-B10F-0C9A0E5E8908

Q34584872-13A81C18-868B-422C-B4D7-E3BDB32764A9

Q34584872-185E4A4D-F9E1-4FA2-9E8F-91C4730175E5

Q34584872-21B57453-61CD-4DF1-A768-EEB39BD07996

Q34584872-23DE509A-DAD0-4D16-975D-D21512A7AC08

Q34584872-2D9EEBDC-E707-4617-AE09-4E8666087A6A

Q34584872-366CA833-F974-45A6-A19C-A72A36AF5634

Q34584872-3A554BC5-5D1D-40FD-B288-9E46C2A82CB0

Q34584872-3BCD5EE9-D354-471E-85E6-C916AC926ADD

Q34584872-416DF267-590B-4224-8EC5-24631C4E4869

P304

Q34584872-32FA7C57-741D-48EB-BEC0-DC87F534C022

P31

Q34584872-F3C3CE4D-ED39-4297-9C75-CFB3EA25B94D

P356

Q34584872-9A5C4691-E01B-4122-B98E-5BCE125A5631

P433

Q34584872-25FCA95F-8164-4B23-A2D7-FB699B16C7C7

P478

Q34584872-36576F9D-07A5-4B96-B0B3-43BAEA5FD598

P50

Q34584872-5B6AEB3B-783A-4AAC-97FA-5D1D4076BC5A

Q34584872-8D33CEAF-033F-4182-92D5-B015D698962D

Q34584872-A5738A54-612D-4A8B-9A99-C4B55624A097

P577

Q34584872-7448FA35-3CF2-4E41-816D-C44A46434608

P5875

Q34584872-4D028C51-5F3C-4B01-ADB5-C548CF2EE1D3

P698

Q34584872-63D33BDC-28EE-4543-BCF7-A6935FEFC1D6

P932

Q34584872-965FF890-1AEA-4402-8EE4-93FF2E1C0973

P356

J.CCR.2010.10.035

P1433

P1476

EZH2 promotes expansion of bre ...... n of RAF1-β-catenin signaling.

@en

P2093

Chun-Ju Chang

http://www.w3.org/2001/XMLSchema#string

Chun-Te Chen

http://www.w3.org/2001/XMLSchema#string

Gabriel N Hortobagyi

http://www.w3.org/2001/XMLSchema#string

Jer-Yen Yang

http://www.w3.org/2001/XMLSchema#string

Jung-Mao Hsu

http://www.w3.org/2001/XMLSchema#string

Mien-Chie Hung

http://www.w3.org/2001/XMLSchema#string

Weiya Xia

http://www.w3.org/2001/XMLSchema#string

P2860

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells

Prospective identification of tumorigenic breast cancer cells

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Epithelial-mesenchymal transitions in development and disease

Stem cells, cancer, and cancer stem cells

The Hedgehog and Wnt signalling pathways in cancer

Genome instability: a mechanistic view of its causes and consequences

Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content

The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells

P304

86-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2010.10.035

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Wendy A Woodward

P577

2011-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49737778

http://www.w3.org/2001/XMLSchema#string

P698

21215703

http://www.w3.org/2001/XMLSchema#string

P932

3041516

http://www.w3.org/2001/XMLSchema#string